Mimedx (MDXG) Total Current Liabilities (2010 - 2026)

Mimedx (MDXG) has 17 years of Total Current Liabilities data on file, last reported at $44.6 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities rose 4.53% year-over-year to $44.6 million; the trailing twelve-month figure through Mar 2026 stood at $44.6 million (up 4.53% YoY), and the FY2025 full-year result was $64.3 million, up 40.95% from the prior year.
• Total Current Liabilities eased to $44.6 million in Q1 2026, from $64.3 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $64.3 million in Q4 2025 to a low of $36.6 million in Q1 2022.
• A 5-year average of $45.1 million and a median of $43.6 million in 2023 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities sank 33.96% in 2022 and surged 40.95% in 2025, its largest moves.
• Tracing MDXG's Total Current Liabilities over 5 years: stood at $43.6 million in 2022, then rose by 5.63% to $46.0 million in 2023, then retreated by 0.9% to $45.6 million in 2024, then surged by 40.95% to $64.3 million in 2025, then tumbled by 30.68% to $44.6 million in 2026.
• Business Quant data shows MDXG's Total Current Liabilities at $44.6 million in Q1 2026, $64.3 million in Q4 2025, and $57.7 million in Q3 2025.